OLI recorded this information on 3/12/2015
$Amount Announced Repurchased:
Under the terms of the ASR, MEDNAX will repurchase $200 million of its common stock, with an aggregate initial delivery of approximately 2.2 million shares. The final number of shares to be repurchased will be based on the volume-weighted average share price of the company's common stock during the term of the ASR, minus a discount. The final settlement of the transactions under the ASR is expected to occur in up to nine months. The Company is funding the ASR with borrowings under its credit facility.
Mednax is a provider of physician services including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. Co.'s network comprised of physicians, including physicians who provide neonatal clinical care and physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies. Co.'s network also includes other pediatric subspecialists, including physicians who provide pediatric intensive care, pediatric cardiology care, hospital-based pediatric care, pediatric surgical care and urology services, pediatric ear, nose and throat services, and pediatric ophthalmology.
MD SEC Filing Email Alerts Service
Open the MD Page at The Online Investor »
Hold (1.50 out of 4)